Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines

NCT01814670 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
185
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan